Zoetis U.S. — Cost of Sales decreased by 8.9% to $194.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 2.5%, from $199.00M to $194.00M. Over 4 years (FY 2021 to FY 2025), U.S. — Cost of Sales shows relatively stable performance with a 1.7% CAGR. This is a positive signal — lower values indicate better performance for this metric.
An increase relative to revenue may suggest rising input costs or supply chain inefficiencies, while a decrease suggests improved manufacturing productivity.
This represents the direct costs attributable to the production and distribution of goods sold within the United States...
Comparable to Cost of Goods Sold (COGS) for domestic segments in manufacturing-heavy industries.
zts_segment_u_s_cost_of_sales| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $192.00M | $199.00M | $213.00M | $185.00M | $198.00M | $204.00M | $216.00M | $203.00M | $214.00M | $228.00M | $255.00M | $217.00M | $232.00M | $258.00M | $229.00M | $199.00M | $208.00M | $222.00M | $213.00M | $194.00M |
| QoQ Change | — | +3.6% | +7.0% | -13.1% | +7.0% | +3.0% | +5.9% | -6.0% | +5.4% | +6.5% | +11.8% | -14.9% | +6.9% | +11.2% | -11.2% | -13.1% | +4.5% | +6.7% | -4.1% | -8.9% |
| YoY Change | — | — | — | — | +3.1% | +2.5% | +1.4% | +9.7% | +8.1% | +11.8% | +18.1% | +6.9% | +8.4% | +13.2% | -10.2% | -8.3% | -10.3% | -14.0% | -7.0% | -2.5% |